754 related articles for article (PubMed ID: 18580211)
1. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
Endo I; Gonen M; Yopp AC; Dalal KM; Zhou Q; Klimstra D; D'Angelica M; DeMatteo RP; Fong Y; Schwartz L; Kemeny N; O'Reilly E; Abou-Alfa GK; Shimada H; Blumgart LH; Jarnagin WR
Ann Surg; 2008 Jul; 248(1):84-96. PubMed ID: 18580211
[TBL] [Abstract][Full Text] [Related]
2. Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience.
Rocha FG; Matsuo K; Blumgart LH; Jarnagin WR
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):490-6. PubMed ID: 19806295
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
[TBL] [Abstract][Full Text] [Related]
4. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
Cercek A; Boerner T; Tan BR; Chou JF; Gönen M; Boucher TM; Hauser HF; Do RKG; Lowery MA; Harding JJ; Varghese AM; Reidy-Lagunes D; Saltz L; Schultz N; Kingham TP; D'Angelica MI; DeMatteo RP; Drebin JA; Allen PJ; Balachandran VP; Lim KH; Sanchez-Vega F; Vachharajani N; Majella Doyle MB; Fields RC; Hawkins WG; Strasberg SM; Chapman WC; Diaz LA; Kemeny NE; Jarnagin WR
JAMA Oncol; 2020 Jan; 6(1):60-67. PubMed ID: 31670750
[TBL] [Abstract][Full Text] [Related]
6. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
Jarnagin WR; Fong Y; DeMatteo RP; Gonen M; Burke EC; Bodniewicz BS J; Youssef BA M; Klimstra D; Blumgart LH
Ann Surg; 2001 Oct; 234(4):507-17; discussion 517-9. PubMed ID: 11573044
[TBL] [Abstract][Full Text] [Related]
7. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
[TBL] [Abstract][Full Text] [Related]
8. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
[TBL] [Abstract][Full Text] [Related]
9. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
Konstantinidis IT; Groot Koerkamp B; Do RK; Gönen M; Fong Y; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR
Cancer; 2016 Mar; 122(5):758-65. PubMed ID: 26695839
[TBL] [Abstract][Full Text] [Related]
10. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients.
Matsuo K; Rocha FG; Ito K; D'Angelica MI; Allen PJ; Fong Y; Dematteo RP; Gonen M; Endo I; Jarnagin WR
J Am Coll Surg; 2012 Sep; 215(3):343-55. PubMed ID: 22749003
[TBL] [Abstract][Full Text] [Related]
11. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y
Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886
[TBL] [Abstract][Full Text] [Related]
12. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases.
Madariaga JR; Iwatsuki S; Todo S; Lee RG; Irish W; Starzl TE
Ann Surg; 1998 Jan; 227(1):70-9. PubMed ID: 9445113
[TBL] [Abstract][Full Text] [Related]
13. Addition of hepatectomy decreases liver recurrence and leads to long survival in hilar cholangiocarcinoma.
Shi Z; Yang MZ; He QL; Ou RW; Chen YT
World J Gastroenterol; 2009 Apr; 15(15):1892-6. PubMed ID: 19370789
[TBL] [Abstract][Full Text] [Related]
14. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
15. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma.
Chauhan A; House MG; Pitt HA; Nakeeb A; Howard TJ; Zyromski NJ; Schmidt CM; Ball CG; Lillemoe KD
HPB (Oxford); 2011 Feb; 13(2):139-47. PubMed ID: 21241432
[TBL] [Abstract][Full Text] [Related]
16. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.
Ribero D; Amisano M; Lo Tesoriere R; Rosso S; Ferrero A; Capussotti L
Ann Surg; 2011 Nov; 254(5):776-81; discussion 781-3. PubMed ID: 22042470
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
[TBL] [Abstract][Full Text] [Related]
18. Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications.
Lin CC; Lin PY; Chen YL
World J Gastroenterol; 2013 Jan; 19(3):375-80. PubMed ID: 23372360
[TBL] [Abstract][Full Text] [Related]
19. Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications.
Igami T; Ebata T; Yokoyama Y; Sugawara G; Takahashi Y; Nagino M
World J Surg; 2011 Nov; 35(11):2501-9. PubMed ID: 21879422
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit.
Saxena A; Chua TC; Sarkar A; Chu F; Morris DL
J Gastrointest Surg; 2010 Jul; 14(7):1128-38. PubMed ID: 20467830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
